Renovorx Inc (RNXT)

$1.16

-0.03

(-2.52%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $1.11
    $1.22
    $1.16
    downward going graph

    4.31%

    Downside

    Day's Volatility :9.02%

    Upside

    4.92%

    downward going graph
  • $0.53
    $2.35
    $1.16
    downward going graph

    54.26%

    Downside

    52 Weeks Volatility :77.42%

    Upside

    50.64%

    downward going graph

Returns

PeriodRenovorx IncIndex (Russel 2000)
3 Months
-5.69%
0.0%
6 Months
2.65%
0.0%
1 Year
-46.3%
0.0%
3 Years
-84.02%
-19.4%

Highlights

Market Capitalization
28.5M
Book Value
$0.11
Earnings Per Share (EPS)
-0.7
Wall Street Target Price
5.63
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-141.87%
Return On Equity TTM
-320.57%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-11.4M
Diluted Eps TTM
-0.7
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.36
EPS Estimate Next Year
-0.38
EPS Estimate Current Quarter
-0.14
EPS Estimate Next Quarter
-0.11

Analyst Recommendation

Buy
    88%Buy
    11%Hold
    0
    0%Sell
Based on 9 Wall street analysts offering stock ratings for Renovorx Inc(by analysts ranked 0 to 5 stars)
Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
6
Hold
1
1
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 385.34%

Current $1.16
Target $5.63

Technicals Summary

Sell

Neutral

Buy

Renovorx Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Renovorx Inc
Renovorx Inc
-10.77%
2.65%
-46.3%
-84.02%
-84.02%
Moderna, Inc.
Moderna, Inc.
-9.87%
21.5%
-2.91%
-60.58%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
1.84%
12.81%
47.11%
81.12%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-6.7%
24.69%
59.95%
200.63%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.28%
11.69%
35.86%
150.1%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Renovorx Inc
Renovorx Inc
NA
NA
NA
-0.36
-3.21
-1.42
NA
0.11
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Renovorx Inc
Renovorx Inc
Buy
$28.5M
-84.02%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Renovorx Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 59.9% return, outperforming this stock by 106.2%

Institutional Holdings

  • Watch Point Trust Co

    0.41%
  • Geode Capital Management, LLC

    0.28%
  • Vanguard Group Inc

    0.24%
  • Charles Schwab Investment Management Inc

    0.21%
  • BlackRock Inc

    0.09%
  • State Street Corporation

    0.08%

Company Information

renovorx is a medical device company headquartered in silicon valley, california. we are developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents, to selected sites in the peripheral vascular system. the ability to deliver these materials at high concentration to specific vasculature, safely and without perfusion overlap to other regions, is a central paradigm of our technology. we have received fda clearance for the renovocath™ rc120 and are now introducing our innovative technology to the clinical market. renovorx is a highly motivated team with broad experience and an exciting vision for the future of targeted delivery. we are backed by a broad medical advisory board and a strong board of directors. please contact us at info@renovorx.com to learn more.

Organization
Renovorx Inc
Employees
10
CEO
Dr. Ramtin Agah M.D.
Industry
Miscellaneous

FAQs